Lataa...
Rare diseases and orphan drugs: Latvian story
BACKGROUND: Ten years have passed since Latvia became a Member State of the EU in 2004. As a result European regulations, including those related to rare diseases and orphan drugs, have been applied to Latvian legislative system. Orphan diseases have been recognized as a priority area for action in...
Tallennettuna:
| Päätekijät: | , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BioMed Central
2014
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4172941/ https://ncbi.nlm.nih.gov/pubmed/25231378 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13023-014-0147-z |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|